EFFECTS OF NON-ENZYMATIC GLYCATION ON THE ANTI-INFLAMMATORY PROPERTIES OF APOLIPOPROTEIN A-I

被引：0
|
作者：
Rye, K. [1 ]
机构：
[1] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evidence that glycation of apolipoprotein A-I inhibits the anti-inflammatory properties of HDL in vivo
    Nobecourt, E.
    Puranik, R. A. J.
    Bao, S.
    Davies, M.
    Barter, P.
    Rye, K. -A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 71 - 71
  • [2] Anti-inflammatory effects of apolipoprotein A-I in the rabbit
    Patel, Sanjay
    Di Bartolo, Belinda A.
    Nakhla, Shirley
    Heather, Alison K.
    Mitchell, Todd W.
    Jessup, Wendy
    Celermajer, David S.
    Barter, Philip J.
    Rye, Kerry-Anne
    ATHEROSCLEROSIS, 2010, 212 (02) : 392 - 397
  • [3] Anti-inflammatory mechanism of Apolipoprotein A-I
    Tao, Xia
    Tao, Ran
    Wang, Kaiyang
    Wu, Lidong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I
    Nobecourt, E.
    Zeng, J.
    Davies, M. J.
    Brown, B. E.
    Yadav, S.
    Barter, P. J.
    Rye, K. -A.
    DIABETOLOGIA, 2008, 51 (06) : 1008 - 1017
  • [5] Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I
    E. Nobécourt
    J. Zeng
    M. J. Davies
    B. E. Brown
    S. Yadav
    P. J. Barter
    K.-A. Rye
    Diabetologia, 2008, 51
  • [6] Structural and functional consequences of non-enzymatic glycation of apolipoprotein A-I and its impact on the reverse cholesterol transport
    Calvo, C
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 114 - 114
  • [7] Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
    Anantharamaiah, G. M.
    Mishra, Vinod K.
    Garber, David W.
    Datta, Geeta
    Handattu, Shaila P.
    Palgunachari, Mayakonda N.
    Chaddha, Manjula
    Navab, Mohamad
    Reddy, Srinivasa T.
    Segrest, Jere P.
    Fogelman, Alan M.
    JOURNAL OF LIPID RESEARCH, 2007, 48 (09) : 1915 - 1923
  • [8] Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus
    Liu, Donghui
    Ji, Liang
    Zhao, Mingming
    Wang, Yang
    Guo, Yansong
    Li, Ling
    Zhang, Dongmei
    Xu, Liang
    Pan, Bing
    Su, Jinzi
    Xiang, Song
    Pennathur, Subramaniam
    Li, Jingxuan
    Gao, Jianing
    Liu, Pingsheng
    Willard, Belinda
    Zheng, Lemin
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 122 : 47 - 57
  • [9] Anti-Inflammatory Functions of Apolipoprotein A-I and High-Density Lipoprotein Are Preserved in Trimeric Apolipoprotein A-I
    Murphy, Andrew J.
    Anh Hoang
    Aprico, Andrea
    Sviridov, Dmitri
    Chin-Dusting, Jaye
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (01): : 41 - 49
  • [10] THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED
    Tabet, F.
    Lambert, G.
    Jenkins, A.
    Barter, P.
    Rye, K-a
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345